咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Profile of People Living with ... 收藏

Profile of People Living with Human Immunodeficiency Virus Initiating Treatment in the Dolutegravir Era in Kinshasa, Democratic Republic of Congo

Profile of People Living with Human Immunodeficiency Virus Initiating Treatment in the Dolutegravir Era in Kinshasa, Democratic Republic of Congo

作     者:Berry I. Bongenya Benoit O. Kabengele Marie-Thérèse A. S. Sombo Guy M. M. Bumoko Hippolyte N. T. Situakibanza Fridolin K. K. Kodondi Gauthier K. Mesia Mariano M. Lusakibanza Jean Marie N. Kayembe Georges L. Mvumbi Baudouin B. Buassa Richard L. Kalala Erick N. Kamangu Berry I. Bongenya;Benoit O. Kabengele;Marie-Thérèse A. S. Sombo;Guy M. M. Bumoko;Hippolyte N. T. Situakibanza;Fridolin K. K. Kodondi;Gauthier K. Mesia;Mariano M. Lusakibanza;Jean Marie N. Kayembe;Georges L. Mvumbi;Baudouin B. Buassa;Richard L. Kalala;Erick N. Kamangu

作者机构:Faculty of Medicine Bel Campus Technological University Kinshasa Democratic Republic of Congo “HIV/AIDS Focus” Research Group Kinshasa Democratic Republic of Congo Department of Internal Medicine Faculty of Medicine University of Kinshasa Kinshasa Democratic Republic of Congo Department of Neurology Faculty of Medicine University of Kinshasa Kinshasa Democratic Republic of Congo Laboratory of Biochemistry Faculty of Pharmaceutical Sciences University of Kinshasa Kinshasa Democratic Republic of Congo Clinical Pharmacology Unit Department of Pharmacology Faculty of Medicine and Pharmaceutical Sciences University of Kinshasa Kinshasa Democratic Republic of Congo Service of Molecular Biochemistry Department of Basic Sciences Faculty of Medicine University of Kinshasa Kinshasa Democratic Republic of Congo 

出 版 物:《World Journal of AIDS》 (艾滋病(英文))

年 卷 期:2023年第13卷第3期

页      面:95-115页

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主  题:Profile PLHIV Starting of ART Dolutegravir Kinshasa 

摘      要:Background: For several decades, the introduction of AntiRetrovirals (ARVs) has improved the symptomatology of People Living with HIV (PLHIV), a spectacular reduction in morbidity and mortality, an improvement in life expectancy and quality of life of PLHIV. Objective: The objective of this study was to determine the profile of PLHIV initiating AntiRetroViral Treatment (ART) in the era of Dolutegravir in Kinshasa. Methods: Cross-section of a prospective cohort to determine the profile of PLHIV initiating ART in Kinshasa. The inclusions were from October 04, 2021 to February 15, 2022. Confirmation of the diagnosis was carried out by Nested PCR. The inclusion criteria were: being at least 18 years old, confirmed HIV positive, naïve to ART, consenting and having signed an informed consent. The parameters of interest followed for the present study were: age, sex, religion, level of study, marital status, occupation, height, weight, body mass index (BMI), the clinical profile, the opportunistic infections as well as the para-clinical assessment (biochemistry and molecular biology). Results: 67 (56.3%) women and 52 (43.7%) men were included, thus 119 patients, all confirmed positive for HIV by Nested PCR on the gag, pol and env regions. The average age of the patients included is 39.87 ± 12.36 years and the most represented age group is that of 36 to 45 years with 37 patients (31.9%). The average height was 1.66 ± 0.08 meters, with an average weight of 56.41 ± 13.30 kg, giving an average Body Mass Index (BMI) of 21.54 ± 5.17 kg/m2. The majority of patients were married (46.1%), of Protestant religion (70.7%), with secondary education (66.7%), and working in the informal sector (29.4%). 49 patients (41.5%) were in clinical stage 3 and 55 patients (47.0%) had a normal clinical status. Malaria (45.4%) and tuberculosis (29.4%) were the most common Opportunistic Infections. The mean values of the patients’ assessed biochemical parameters were within the ranges. The

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分